TY - JOUR
T1 - European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia
AU - Lucas, Jane S.
AU - Barbato, Angelo
AU - Collins, Samuel A.
AU - Goutaki, Myrofora
AU - Behan, Laura
AU - Caudri, Daan
AU - Dell, Sharon
AU - Eber, Ernst
AU - Escudier, Estelle
AU - Hirst, Robert A.
AU - Hogg, Claire
AU - Jorissen, Mark
AU - Latzin, Philipp
AU - Legendre, Marie
AU - Leigh, Margaret W.
AU - Midulla, Fabio
AU - Nielsen, Kim G.
AU - Omran, Heymut
AU - Papon, Jean Francois
AU - Pohunek, Petr
AU - Redfern, Beatrice
AU - Rigau, David
AU - Rindlisbacher, Bernhard
AU - Santamaria, Francesca
AU - Shoemark, Amelia
AU - Snijders, Deborah
AU - Tonia, Thomy
AU - Titieni, Andrea
AU - Walker, Woolf T.
AU - Werner, Claudius
AU - Bush, Andrew
AU - Kuehni, Claudia E.
N1 - Publisher Copyright:
Copyright © ERS 2017.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2017/1/4
Y1 - 2017/1/4
N2 - The diagnosis of primary ciliary dyskinesia is often confirmed with standard, albeit complex and expensive, tests. In many cases, however, the diagnosis remains difficult despite the array of sophisticated diagnostic tests. There is no "gold standard" reference test. Hence, a Task Force supported by the European Respiratory Society has developed this guideline to provide evidence-based recommendations on diagnostic testing, especially in light of new developments in such tests, and the need for robust diagnoses of patients who might enter randomised controlled trials of treatments. The guideline is based on pre-defined questions relevant for clinical care, a systematic review of the literature, and assessment of the evidence using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach. It focuses on clinical presentation, nasal nitric oxide, analysis of ciliary beat frequency and pattern by high-speed video-microscopy analysis, transmission electron microscopy, genotyping and immunofluorescence. It then used a modified Delphi survey to develop an algorithm for the use of diagnostic tests to definitively confirm and exclude the diagnosis of primary ciliary dyskinesia; and to provide advice when the diagnosis was not conclusive. Finally, this guideline proposes a set of quality criteria for future research on the validity of diagnostic methods for primary ciliary dyskinesia.
AB - The diagnosis of primary ciliary dyskinesia is often confirmed with standard, albeit complex and expensive, tests. In many cases, however, the diagnosis remains difficult despite the array of sophisticated diagnostic tests. There is no "gold standard" reference test. Hence, a Task Force supported by the European Respiratory Society has developed this guideline to provide evidence-based recommendations on diagnostic testing, especially in light of new developments in such tests, and the need for robust diagnoses of patients who might enter randomised controlled trials of treatments. The guideline is based on pre-defined questions relevant for clinical care, a systematic review of the literature, and assessment of the evidence using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach. It focuses on clinical presentation, nasal nitric oxide, analysis of ciliary beat frequency and pattern by high-speed video-microscopy analysis, transmission electron microscopy, genotyping and immunofluorescence. It then used a modified Delphi survey to develop an algorithm for the use of diagnostic tests to definitively confirm and exclude the diagnosis of primary ciliary dyskinesia; and to provide advice when the diagnosis was not conclusive. Finally, this guideline proposes a set of quality criteria for future research on the validity of diagnostic methods for primary ciliary dyskinesia.
UR - http://www.scopus.com/inward/record.url?scp=85008490006&partnerID=8YFLogxK
U2 - 10.1183/13993003.01090-2016
DO - 10.1183/13993003.01090-2016
M3 - Review article
C2 - 27836958
AN - SCOPUS:85008490006
SN - 0903-1936
VL - 49
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 1
M1 - 1601090
ER -